| Date Filed | Type | Description |
| 08/10/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 08/03/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 07/24/2023 |
8-K
| Quarterly results |
| 07/17/2023 |
SC 13G
| BML Investment Partners, L.P. reports a 5.1% stake in Quince Therapeutics, Inc. |
| 05/25/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 04/14/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 04/14/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/14/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 04/05/2023 |
8-A12B
| Form 8-A12B - Registration of securities [Section 12(b)]: |
| 04/05/2023 |
8-K
| Entry into a Material Definitive Agreement, Material Modifications to Rights of Security Holders, Amendments to Articles of I... |
| 04/04/2023 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 03/31/2023 |
SC 13G
| TANG CAPITAL PARTNERS LP reports a 10% stake in Quince Therapeutics, Inc. |
| 03/28/2023 |
8-K
| Quarterly results |
| 03/15/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 03/15/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/30/2023 |
8-K
| Results of Operations and Financial Condition, Cost Associated with Exit or Disposal Activities, Other Events &nbs... |
| 01/27/2023 |
8-K
| Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of... |
| 12/16/2022 |
8-K
| Quarterly results |
| 11/09/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 09/30/2022 |
8-K
| Quarterly results |
| 08/09/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 08/01/2022 |
8-K
| Results of Operations and Financial Condition, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Othe... |
| 07/22/2022 |
8-K
| Quarterly results |
| 07/08/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 06/10/2022 |
8-K
| Quarterly results |
| 05/25/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 05/20/2022 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 05/20/2022 |
8-K
| Quarterly results |
| 05/19/2022 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 05/18/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 05/12/2022 |
8-K
| Director compensation was amended/approved |
| 05/10/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
| 05/10/2022 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
|